USPTO serial 99834531
REZIMUNE
Status 641Office Action
- Filing date
- May 20, 2026
- Status date
- Aug 27, 2026
- Registration date
- —
- Examiner
- GERHART, NIKOLAUS C
Need help with REZIMUNE?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: November 27, 2026
Office Action issues
The examiner refused your trademark due to potential confusion with an existing registration [Serial No. 85547028, Registration No. 4597602] and requested additional technical information about your goods.
Owner
Biophilia LLC
Mullica Hill, NJ, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for cellular therapy for the treatment of autoimmune disease | ACTIVE | — |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Aug 27, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 27, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Aug 27, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Jul 29, 2026 | DOCK | ASSIGNED TO EXAMINER |
| May 20, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| May 20, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| May 20, 2026 | NWAP | NEW APPLICATION ENTERED |